Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00273182 · ClinicalTrials.gov registry record

InSync Model 8040 (InSync) and InSync III Model 8042 (InSync III) Registry

A clinical trial of Heart Failure and Cardiomyopathy, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

Completed
Registry status
1,999
Enrollment target
20
Study locations

NCT00273182 is a study of Heart Failure and Cardiomyopathy that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 1,999 participants, roughly in line with the 2,044-participant average among 397 other Heart Failure trials with a reported enrollment target. The trial reports 20 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00273182, a study of Heart Failure and Cardiomyopathy, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

COMPLETED
Registry status
1,999 participants
Enrollment target
20
Study locations

Study Summary

Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. When there are changes in the heart beat sometimes an implantable heart device is used to control the rate and rhythm of the heart beat. In certain heart failure cases, when the two lower chambers of the heart no longer beat in a coordinated manner, cardiac resynchronization therapy (CRT) may be prescribed. CRT is similar to a pacemaker. It is placed (implanted) under the skin of the upper chest. CRT is delivered as tiny electrical pulses to the right and left ventricles through three or four leads (soft insulated wires) that are inserted through the veins to the heart. The purpose of this study is to monitor the long-term performance of the InSync Model 8040 (InSync) and InSync III Model 8042 (InSync III) systems for cardiac resynchronization therapy (CRT).

Conditions Studied

Heart Failure Cardiomyopathy

Interventions

  • DEVICE InSync Model 8040
  • DEVICE InSync III Model 8042

Study Locations (20)

Florida

  • - Gainesville
  • - Jacksonville
  • - Jupiter
  • - Melbourne
  • - Miami
  • - Orlando
  • - Tampa

California

  • - Long Beach
  • - Napa
  • - Oxnard
  • - San Diego
  • - Yuba City

Arkansas

  • - Fort Smith
  • - Little Rock

Illinois

  • - Rockford
  • - Springfield

Alabama

  • - Birmingham

Arizona

  • - Peoria

District of Columbia

  • - Washington D.C.

Georgia

  • - Atlanta

Trial Details

FieldValue
Enrollment Target 1,999 participants
Start Date 2002-03
Est. Completion 2011-04

Sponsor

Medtronic Cardiac Rhythm and Heart Failure

115 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00273182

The ClinicalTrials.gov registry entry for NCT00273182 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,999 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 2,044-participant average among 397 other Heart Failure trials with a reported enrollment target. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which InSync Model 8040 is the first listed.

NCT00273182 reports 20 study locations spanning 8 distinct geographic areas - top geographies include Florida, California, Arkansas.

Frequently Asked Questions

What is clinical trial NCT00273182 about?

NCT00273182 is a clinical study titled "InSync Model 8040 (InSync) and InSync III Model 8042 (InSync III) Registry". Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. When there are changes in the heart beat sometimes an implantable heart device is used to control the rate and rhythm of the hea...

What is the current status of trial NCT00273182?

This trial is currently completed. The enrollment target is 1,999 participants. The study started on 2002-03. Estimated completion is 2011-04.

What conditions does trial NCT00273182 study?

This clinical trial studies the following conditions: Heart Failure, Cardiomyopathy.

What interventions are being tested in trial NCT00273182?

The interventions under investigation include: InSync Model 8040 (DEVICE), InSync III Model 8042 (DEVICE).

Who is sponsoring clinical trial NCT00273182?

This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00273182 being conducted?

This trial has 20 study locations across Alabama, Arizona, Arkansas, California, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Heart Failure

All registered trials for this condition

Cardiomyopathy

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.